Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions☆
Section snippets
Methods
This was a cohort study of families with age-related maculopathy consisting of a minimum of two individuals affected with ARM.
Probands of ARM families were initially identified by mailings from ophthalmology and vitreoretinal practices to patients with ARM from the past 3 years, as identified from medical billing records. This practice-based survey approach for families with ARM has been described elsewhere.8 Patients indicated their interest in being contacted by the study coordinators by
Results
The characteristics of the families with ARM are summarized in Table 1 (ages, gender, and percent exudative). Under model A, 72% of the genotyped affected individuals had evidence of a choroidal neovascularization in one or both eyes. In model B, the percentage decreased to 67%, because we included less advanced cases of ARM. Model C incorporated an additional group of affected individuals with a total of 65% of the cohort having exudative ARM. Under our least stringent model, we evaluated 391
Discussion
This study is not intended to be an independent replication of our first genome-wide scan but rather reflects an ongoing effort to expand our genetic studies to increase our power to detect linkage. We have nearly doubled the informativeness of the second set of families, while using the same diagnostic criteria, by the recruitment of additional siblings. The allele frequencies for the two sets of families are not identical (in part because of the fact that the genotyping was performed at
Participating centers and clinicians
Seneca Eye Surgeons, Warren, PA; Erie Retinal Surgery, Inc, Erie, PA; University Eye Care, University of Pittsburgh, Pittsburgh, PA; private offices of Drs Berk, S. Portnoy, R. Barad, G. Gerneth, D. Nadler, and T. Gordon in Pittsburgh, PA; Retinal Associates of Cleveland, Cleveland, OH; Division of Vitreoretinal Surgery, Cole Eye Institute, Cleveland Clinic, Cleveland, OH; Associated Retinal Consultants PC, Detroit, MI; Texas Retina Associates, Dallas, TX; Division of Vitreoretinal Surgery,
Acknowledgements
Our first genome-wide scan was genotyped by the NHLBI MGS (http://research.marshfieldclinic.org/genetics/), which is led by Dr James Weber. Genotyping services for our second genome-wide scan were provided by the CIDR.
We are grateful for the personal efforts of Kim Doheny and Elizabeth Pugh, PhD, who assisted us with the CIDR sample documentation and data presentation and Tammy Koepel from the NHLBI Mammalian Genotyping Center.
References (32)
- et al.
Prevalence of ocular disease in a population study of subjects 65 years old and older
Am J Ophthalmol
(1982) - et al.
Senile lens and senile macular changes in a population-based sample
Am J Ophthalmol
(1980) - et al.
Genetic association of apolipoprotein E with age-related macular degeneration
Am J Hum Genet
(1998) - et al.
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration
Am J Ophthalmol
(1998) - et al.
PedCheck. A program for identifying genotype incompatibilities in linkage analysis
Am J Hum Genet
(1998) - et al.
Statistical tests for detection of misspecified relationships by use of genome-screen data
Am J Hum Genet
(2000) - et al.
Linkage analysis in the presence of errors IIImarker loci and their map as nuisance parameters
Am J Hum Genet
(2000) - et al.
A multipoint method for detecting genotyping errors and mutations in sibling-pair linkage data
Am J Hum Genet
(2000) - et al.
A twin study of age-related macular degeneration
Am J Ophthalmol
(1995) - et al.
Phenotypic heterogeneity in families with age-related macular degeneration
Am J Ophthalmol
(1997)
Effects of stratification in the analysis of affected-sib-pair databenefits and costs
Am J Hum Genet
Vision in the elderly and its use in the social environment
Scan J Soc Med Suppl
The Framingham Eye Study. I. Outline and major prevalence findings
Am J Epidemiol
Cataracts and macular degeneration in older Americans
Arch Ophthalmol
Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals
Acta Ophthalmologica
Drusen and disciform macular detachment and degeneration
Arch Ophthalmol
Cited by (117)
Future prospects for human genetics and genomics in drug discovery
2023, Current Opinion in Structural BiologyOngoing controversies and recent insights of the ARMS2-HTRA1 locus in age-related macular degeneration
2021, Experimental Eye ResearchPredictive genetics for AMD: Hype and hopes for genetics-based strategies for treatment and prevention
2020, Experimental Eye ResearchCitation Excerpt :As a leading cause of blindness among the elderly, it has been the focus of numerous genetics-based investigations. AMD molecular genetic studies started in the 1990s with the initial association of Apolipoprotein E (ApoE) variants with the condition, and later with family-based linkage studies (Barral et al., 2006; Iyengar et al., 2004; Kenealy et al., 2004; Schick et al., 2003; Seddon et al., 2003; Weeks et al., 2001, 2004). Candidate gene testing and genome-wide association studies (GWAS) then transformed our understanding of the condition in the subsequent decade.
Epigenetics in age-related macular degeneration (AMD) – French translation of the article
2018, Journal Francais d'OphtalmologieEpigenetics in Age-related Macular Degeneration (AMD)
2018, Journal Francais d'OphtalmologieAmerican Journal of Ophthalmology Contributions to Ophthalmic Genetics
2018, American Journal of Ophthalmology
- ☆
This work was supported by Smith-Kettlewell Eye Research Foundation, San Francisco, California (M.B.G., T.O.P.); Ruth and Milton Steinbach Foundation, New York, New York (M.B.G.); Research to Prevent Blindness, New York, New York (M.B.G.); The Eye and Ear Research Foundation, Pittsburgh, Pennsylvania (M.B.G.); Pennsylvania Lions Sight Conservation and Eye Research Foundation, Harrisburg, Pennsylvania (M.B.G.); Grant RO1-EY 09859 National Eye Institute, Bethesda, Maryland (M.B.G.); V. Kann Rasmussen Foundation (P.J.R.). The Mammalian Genotyping Service is funded by National Heart, Lung and Blood Institute under contract number N01-HV-48141 to the Marshfield Medical Research Foundation. Center for Inherited Disease Research is funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number N01-HG-65403.